Key Components of Psychedelic-Assisted Psychotherapy

What Is Psychedelic Assisted Psychotherapy?

Psychedelic-assisted psychotherapy is a therapeutic approach that involves the controlled use of psychedelic substances to facilitate mental health treatment. This method combines the powerful psychoactive effects of psychedelics with traditional psychotherapy techniques to help patients achieve deep psychological insights, emotional breakthroughs, and sustained behavioral changes.

Psychedelic Substances Used In Psychedelic Psychotherapy

Psilocybin: Found in certain species of mushrooms, psilocybin is used to treat depression, anxiety, PTSD, and substance use disorders. It promotes neural plasticity and alters brain activity patterns associated with depression and anxiety.
MDMA: Known for its empathogenic effects, MDMA is primarily used to treat PTSD. It reduces fear and defensiveness, fostering a safe environment for patients to process traumatic memories.
LSD (Lysergic Acid Diethylamide): Used for anxiety, depression, and addiction, LSD induces altered states of consciousness that can lead to profound emotional and cognitive insights.
Ketamine: An NMDA receptor antagonist, ketamine is effective for treatment-resistant depression and suicidal ideation. It provides rapid relief by promoting synaptogenesis and altering dysfunctional neural circuits. Ketamine Assisted Psychotherapy is the only legal psychedelic psychotherapy treatment option in Missouri in at this time. Restoring Clarity Counseling in St. Louis provides Ketamine Assisted Psychotherapy.
Ayahuasca: A traditional Amazonian brew containing DMT, ayahuasca is used for depression, PTSD, and addiction. It induces intense visionary experiences that facilitate emotional and psychological healing.

The Psychedelic Psychotherapy Therapeutic Process

The process typically involves three phases:

Preparation: Clients undergo several preparatory sessions with a therapist to establish trust, set intentions, and prepare for the psychedelic experience. This phase is crucial for building a therapeutic alliance and ensuring the client’s safety and comfort. Preparation helps establish a calming and supportive environment, which is essential for client’s to feel safe and secure during their psychedelic journey. This sense of safety allows clients to explore their inner landscapes and to establish skills to move through the experience without overwhelming anxiety or fear.
Psychedelic Sessions: During the psychedelic session, the client ingests the substance under the supervision of trained therapists in a controlled and supportive setting. The therapists guide the client through the experience, helping them navigate challenging emotions and insights. Music plays a crucial role in psychedelic psychotherapy, serving as an integral component that enhances the therapeutic process. Its carefully curated soundscapes guide clients through their psychedelic experience, facilitating emotional release, introspection, and healing.
Integration: Psychedelic integration refers to taking the gained insights, emotions, or attitudes from your experience, and processing them into desired areas of your life. Integration as a general definition means “bringing parts together to make a whole.” Psychedelic integration helps to achieve a sense of “wholeness” clients seek through their set intentions for treatment. It is a crucial step for ensuring lasting therapeutic benefits. EMDR, Somatic Experiencing, and Internal Family Systems therapies may be utilized to further integrate the knowledge and wisdom you’ve gained as a result of the experience. Following the psychedelic session, integration therapy helps patients make sense of their experiences and incorporate the insights gained into their daily lives. This phase is essential for translating the psychedelic experience into lasting psychological and behavioral change.

Can Psychedelics Enhance Psychotherapeutic Benefits?

Psychedelics induce profound changes in consciousness by interacting with various neurotransmitter systems in the brain, particularly the serotonin system.

These substances can:

Enhance Neural Plasticity: Psychedelics promote the growth of new neural connections, helping to rewire dysfunctional brain circuits associated with mental health disorders.
Reduce Default Mode Network Activity: Many psychedelics decrease activity in the brain’s default mode network (DMN), which is associated with self-referential thinking and rumination. This reduction can lead to a sense of ego dissolution and a heightened sense of connection with the self and others.
Facilitate Emotional Release: Psychedelics can help patients access repressed emotions and memories, allowing for emotional catharsis and resolution of psychological trauma.

Research and Efficacy of Psychedelic Psychotherapy

Numerous studies have demonstrated the efficacy of psychedelic-assisted psychotherapy:

Psilocybin: Research by Johns Hopkins University and Imperial College London has shown significant reductions in depression and anxiety symptoms following psilocybin-assisted therapy sessions.
MDMA: Clinical trials by the Multidisciplinary Association for Psychedelic Studies (MAPS) have reported substantial improvements in PTSD symptoms, with many participants experiencing long-term remission.
Ketamine: Ketamine-assisted psychotherapy (KAP) is gaining recognition as an innovative and effective treatment for various mental health conditions, including PTSD, depression, and anxiety. Ketamine, traditionally used as an anesthetic, has shown remarkable promise in addressing these conditions by rapidly alleviating symptoms and facilitating deep psychological healing.
Ayahuasca: Research conducted in Brazil and Canada has found that ayahuasca can lead to lasting reductions in depression and anxiety symptoms, as well as improvements in mindfulness and psychological well-being.

Safety and Regulation

While psychedelic substances have a history of recreational use and potential for abuse, their administration in a therapeutic setting is carefully controlled to ensure safety. Adverse effects are generally mild and manageable, especially when administered by trained professionals in a supportive environment. Regulatory agencies are increasingly recognizing the potential of psychedelic-assisted psychotherapy. The FDA has granted Breakthrough Therapy Designation to MDMA-assisted psychotherapy for PTSD and psilocybin therapy for depression, expediting the development and review process for these treatments.

Psychedelic-assisted Psychotherapy Next Steps

Psychedelic-assisted psychotherapy represents a promising frontier in mental health treatment, offering new hope for individuals with conditions that have not responded to traditional therapies. By combining the transformative effects of psychedelics with structured therapeutic support, this approach has the potential to revolutionize the field of mental health and provide relief for countless individuals worldwide. As research progresses and regulatory landscapes evolve, psychedelic-assisted psychotherapy may soon become a widely accepted and integral part of mental health care.

Reach out today to see if Ketamine Assisted Psychotherapy is the right treatment for you.